User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

2614

Interactions with Platform & by Email *

INTERACTIONS

471

Unique # Participated *

PARTICIPANTS

78

Responses Validated *

VALIDATIONS

23

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definition and Scope of Study.....I-3  
   Biopreservation - A Critical Activity for Improving Human Healthcare.....II-11$100
   Rapidly Mushrooming Biorepositories Portend Bright Outlook for Market Growth.....II-21$100
   Western Countries Dominate, Developing Economies to Lend Growth Momentum.....II-3
R&D and Therapeutic Applications Corner Bulk of Demand.....II-3
1$100
   Competitive Scenario.....II-4
Biopreservation Market Remains Highly Competitive.....II-4
Table 1: Global Biopreservation Equipment Market by Leading Players (2014): Percentage Market Share Breakdown of Dollar Revenues for Biogenics, BioCision, Cesca Therapeutics, Custom Biogenic Systems, Princeton Cryotech, So-Low Environmental Equipment, Taylor-Wharton Cryogenics, Thermo Fisher Scientific, VWR International, and Others (includes corresponding Graph/Chart).....II-4
1$350
   Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution.....II-51$100
   Improving Healthcare Expenditure Propels Demand.....II-6
Table 2: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart).....II-6
1$350
   Table 3: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart).....II-7
Development of Regenerative Medicine Accelerates Demand for Improved Biopreservation
  Solutions.....II-7
1$350
   Table 4: Global Regenerative Medicines Market by Category (2015E): Percentage Breakdown for Biopharmaceuticals, Cell and Tissue-Based Therapies, and Regenerative Devices & Compounds (includes corresponding Graph/Chart).....II-8
Growing Prevalence of Chronic Diseases Highlights Importance of Maintaining Demographic
  and Age based Databases.....II-8
1$350
   Key Disease Statistics – Opportunity Indicators.....II-9
Table 5: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-9
1$350
   Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).....II-10

Table 7: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).....II-10
1$350
   Table 8: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart).....II-11

Table 9: Global Cost of Respiratory Therapy by Disease (2015): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others (includes corresponding Graph/Chart).....II-11
1$350
   Biopreservation Media Play Pivotal role in Biomarker Exploration and Development of
  Companion Diagnostics.....II-12
Advancements in Personalized Medicine - A Megatrend Catalyzing Growth.....II-12
1$100
   Growing Awareness of Stem Cell Therapy Propels Market Forward, Stem Cell Research in
  Top Gear.....II-13
1$100
   Table 10: Global Stem Cell Usage in Research (2013): Percentage Share Breakdown by Type (includes corresponding Graph/Chart).....II-141$350
   Advancements in Organ and Tissue Banking Critical for Meeting Huge Unmet Demand for
  Transplantations.....II-15
1$100
   Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation.....II-16
New Paradigms in Heart and Lung Preservation.....II-16
1$100
   Several Challenges Remain to be Addressed for Cryopreservation of Complex
  Tissues.....II-17
1$100
   Major Strides Achieved in HBS Sample Tracking Technologies.....II-18
LIMS Suites Integrated with Sample Tracking Modules.....II-18
RFID Tags - Ideal for Cryogenic Applications.....II-18
1$100
   MEMS-Based Tracking Tags Take Biosample Tagging to the Next Level.....II-19
Need for Harmonization and Networking of Biobanks, Supplemented by Biolibraries and
  Virtual Biobanks.....II-19
1$100
   Commercial Biobanks Slowly Gain Acceptance.....II-20
Growing Diversity of HBS Increases Spatial Constraints of Biorepositories.....II-20
1$100
   Dearth of Standardized and Quality Biospecimens Pose Problems.....II-21
Mounting Costs and Funding Cutbacks Undermine Viability of Biopreservation.....II-21
2$200
   Dried Blood Spots at Room Temperature – A Potential Alternative for Cryogenic
  Preservation.....II-23
1$100
   Donor Engagement and Support - Key to Resolving Ethical and Regulatory Hurdles for
  Biorepositories.....II-24
1$100
   Biorepositories Increasingly Adopt Automation to Boost Productivity.....II-251$100
   Dry Storage Vessels to Unseat Ultra-low Freezers.....II-261$100
   Cold Chain Systems - An Overlooked, Albeit Important Aspect of Biopreservation.....II-271$100
   Biopreservation.....II-28
Biopreservation Equipment.....II-28
Biopreservation Media.....II-28
1$100
   Types of Biopreserved Biospecimens.....II-29
Applications of Biopreservation Equipment and Media.....II-29
Therapeutic Applications.....II-29
1$100
   Research Applications.....II-30
Other Applications.....II-30
1$100
   BioLife Solutions Introduces BloodStor 27 NaCl Cryopreservation Media.....II-31
BioCision Submits MAF for ThawSTAR Automated Cell Thawing System to USFDA.....II-31
BioCision Releases CryoPod Carrier.....II-31
BioLife Solutions Unveils New Packages for BloodStor and CryoStor Cryopreservation
  Media.....II-31
BioCision Launches ThawSTAR™ Automated Sample Thawing System.....II-31
BioCision LLC Introduces BioT Temperature Stability Systems.....II-31
Panasonic Debuts New Biomedical Freezer Line for -30°C Storage.....II-31
1$100
   Asterand Bioscience Takes Over AdeptBio.....II-32
Roche Acquires Signature Diagnostics.....II-32
Cyprus, The University of Cyprus to Purchase Biobank.....II-32
Monash University Commences Biorepository in Alfred Medical Research & Education
  Precinct.....II-32
LabConnect Shifts Operations Center to New Facility.....II-32
Cardio3 BioSciences Adopts BioLife CryoStor Cryopreservation Media for CHART Clinical
  Trials.....II-32
Cord Blood Registry Selects BioLife’s CryoStor Media for Umbilical Cord Stem Cell
  Storage.....II-32
1$100
   Mayo Clinic Selects BioLife CryoStor Cell Freeze Media for Pediatric CHD Study.....II-33
BioCision to Collaborate with Celgene Cellular Therapeutics for Developing
  ThawSTAR.....II-33
TxCell Selects BioCision’s Temperature Standardization Products for Ovasave Phase
  IIb Clinical Trial.....II-33
Brooks Automation Invests into, Collaborates with BioCision.....II-33
Adaptimmune Adopts BioLife Solutions’ CryoStor Cell Freeze Media for Phase I/II,
  Cell-Based Cancer Therapy.....II-33
BioLife Solutions, SAVSU Technologies Forms Joint Venture Company, biologistex
  CCM.....II-33
1$100
   Parcell Laboratories Selects BioLife Solutions’ CryoStor Media for ELA Stem Cell
  Studies.....II-34
RoosterBio Selects BioLife Solutions’ CryoStor Cryopreservation Media for
  Commercializing hMSC Products.....II-34
Cesca Therapeutics Secures Contract from Upstate Cord Blood Bank.....II-34
SeraCare Life Sciences Divests Biorepository Business to Precision Health
  Holdings.....II-34
Mayo Clinic Establishes Biobank in Arizona for Population-wide Study.....II-34
Department of Veterans Affairs Commences Gulf War Veterans’ Illnesses
  Biorepository.....II-34
Apollo JV with Saarum Innovations Sets Up First-ever Commercial Biobank in
  India.....II-34
1$100
   AstraZeneca Establishes Biobank and Clinical Research Center in Russia.....II-35
BioCision Announces Collaboration with ATCC.....II-35
China National Genebank Partners with BioStorage Technologies.....II-35
DaVita Labs and Myriad RBM Collaborate for Renal Disease Studies.....II-35
Laboratory Corporation of America Secures CAP Accreditation for LabCorp
  Biorepository.....II-35
AMSBIO Expands Biorepository and Collection Services.....II-35
Cell Therapy Catapult, Roslin Cells to Set Up Pluripotent Stem Cells Biobank.....II-35
1$100
   Atlanta Biologicals, Inc. (USA).....II-36
Biocision LLC (USA).....II-36
1$100
   Biogenics Inc. (USA).....II-37
Biolife Solutions, Inc. (USA).....II-37
1$100
   Cell & Tissue Systems, Inc. (USA).....II-38
Cesca Therapeutics Inc. (USA).....II-38
1$100
   Core Dynamics, Ltd. (Israel).....II-39
Custom Biogenic Systems, Inc. (USA).....II-39
Essential Pharmaceuticals LLC (USA).....II-39
1$100
   Lifeline Scientific, Inc. (USA).....II-40
Panasonic Biomedical Sales Europe B.V. (The Netherlands).....II-40
1$100
   Preservation Solution, Inc. (USA).....II-411$100
   Princeton Cryotech, Inc. (USA).....II-42
Sigma-Aldrich Corporation (USA).....II-42
1$100
   So-Low Environmental Equipment Co., Inc. (USA).....II-43
Taylor-Wharton Cryogenics LLC (USA).....II-43
1$100
   Thermo Fisher Scientific, Inc. (USA).....II-441$100
   VWR International LLC (USA).....II-45
Wak-Chemie Medical Gmbh (Germany).....II-45
1$100
   Table 11: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-461$350
   Table 12: World 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....II-471$350
   Table 13: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Product Segment - Equipment and Media Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-481$350
   Table 14: World 8-Year Perspective for Biopreservation Equipment and Media by Product Segment - Percentage Share Breakdown of Dollar Revenues for Equipment and Media Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....II-491$350
   Table 15: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Application - R&D, Therapeutic, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-501$350
   Table 16: World 8-Year Perspective for Biopreservation Equipment and Media by Application - Percentage Share Breakdown of Dollar Revenues for R&D, Therapeutic, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....II-511$350
   Table 17: World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Biospecimen Type - Organs, Stem Cells, Tissues, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-521$350
   Table 18: World 8-Year Perspective for Biopreservation Equipment and Media by Biospecimen Type - Percentage Share Breakdown of Dollar Revenues for Organs, Stem Cells, Tissues, and Others Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....II-531$350
   A. Market Analysis.....III-1
United States: The Single Largest Market for Biopreservation.....III-1
Innovative Biopreservation Approaches Critical for Transplantation Research.....III-1
Table 19: Waiting List of Patients for Organ Transplants by Organ Type: As of August 2014 (includes corresponding Graph/Chart).....III-1
1$200
   Table 20: The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart).....III-21$200
   Robust Demand for Regenerative Medicines Augurs Well for Biopreservation solutions
  Market.....III-3
1$75
   Aging Population, Rising Incidence of Chronic Diseases Fuel Demand for
  Biobanking.....III-4
Table 21: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-4
1$200
   Table 22: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).....III-5

Table 23: New Cancer Cases in Males in US by Body Site (2014) (includes corresponding Graph/Chart).....III-5
1$200
   Table 24: New Cancer Cases in Females in US by Body Site (2014) (includes corresponding Graph/Chart).....III-6
Product Introductions.....III-6
1$200
   Strategic Corporate Developments.....III-73$225
   Select Key Players.....III-109$675
   B. Market Analytics.....III-19
Table 25: The US Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-19
1$200
   A. Market Analysis.....III-20
Current and Future Analysis.....III-20
Canada Emerges as a Significant Player in the Field of Regenerative
  Medicine.....III-20
Canadians More Receptive to Organ Transplants.....III-20
1$75
   Table 26: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2012 (includes corresponding Graph/Chart).....III-21
B. Market Analytics.....III-21
Table 27: Canadian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-21
1$200
   A. Market Analysis.....III-22
Current and Future Analysis.....III-22
Urgent Need for Regenerative Therapeutics in Geriatric Healthcare and Cancer Care to
  Drive Demand for Biopreservation Media.....III-22
1$75
   Table 28: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-23

Table 29: Cancer Related Deaths by Age Group in Japan (2013) (includes corresponding Graph/Chart).....III-23
1$200
   B. Market Analytics.....III-24
Table 30: Japanese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-24
1$200
   A. Market Analysis.....III-25
Current and Future Analysis.....III-25
Ageing Population to Drive Demand for Regenerative Medicines.....III-25
1$75
   Table 31: European Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-261$200
   Table 32: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....III-271$200
   Increasing Organ Transplantations Drive the Need for Preservation.....III-28
Table 33: European Deceased Organ Donation Rates Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart).....III-28

Table 34: European Living Organ Donation Rates Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart).....III-28
1$200
   Table 35: European Single Organ Transplantations by Select Country and Organ Type: 2013.....III-29

Table 36: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013.....III-29
Cancer in Europe: Key Statistics.....III-29
Table 37: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart).....III-29
1$200
   B. Market Analytics.....III-30
Table 38: European Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-30
1$200
   Table 39: European 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for France, Germany, Italy, UK, Spain, Russia, The Netherlands, and Rest of Europe Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....III-311$200
   Market Analysis.....III-32
Table 40: French Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   A. Market Analysis.....III-33
Current and Future Analysis.....III-33
Germany Holds Strong Position in European Regenerative Medicine Sector.....III-33
Strategic Corporate Development.....III-33
Wak-Chemie Medical Gmbh – A Key German Player.....III-33
1$75
   B. Market Analytics.....III-34
Table 41: German Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   A. Market Analysis.....III-35
Current and Future Analysis.....III-35
B. Market Analytics.....III-35
Table 42: Italian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-35
1$200
   A. Market Analysis.....III-36
Current and Future Analysis.....III-36
NHS Initiatives for Promulgating Organ Translation Ramp up Usage of Organ
  Preservation Solutions.....III-36
Table 43: The UK Organ Donors by Type: May 2015 & May 2014 (includes corresponding Graph/Chart).....III-36
1$200
   Table 44: The UK Organ Transplantation by Type: 2014 Vs. 2015 (includes corresponding Graph/Chart).....III-37
Strategic Corporate Development.....III-37
1$200
   B. Market Analytics.....III-38
Table 45: UK Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-38
1$200
   A. Market Analysis.....III-39
Current and Future Analysis.....III-39
B. Market Analytics.....III-39
Table 46: Spanish Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-39
1$200
   A. Market Analysis.....III-40
Current and Future Analysis.....III-40
Strategic Corporate Development.....III-40
1$75
   B. Market Analytics.....III-41
Table 47: Russian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-41
1$200
   A. Market Analysis.....III-42
Current and Future Analysis.....III-42
Panasonic Biomedical Sales Europe B.V. – A Key Dutch Player.....III-42
1$75
   B. Market Analytics.....III-43
Table 48: The Netherlands Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-43
1$200
   A. Market Analysis.....III-44
Current and Future Analysis.....III-44
B. Market Analytics.....III-44
Table 49: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-44
1$200
   A. Market Analysis.....III-45
Current and Future Analysis.....III-45
India & China Offer Significant Growth Opportunities.....III-45
1$75
   Table 50: Population Statistics in Select Asian Countries & Percentage of Population Aged Above 65 Years (includes corresponding Graph/Chart).....III-461$200
   Organ Transplantation Statistics.....III-47
Table 51: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart).....III-47

Table 52: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart).....III-47
1$200
   B. Market Analytics.....III-48
Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-48
1$200
   Table 54: Asia-Pacific 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....III-491$200
   A. Market Analysis.....III-50
Current and Future Analysis.....III-50
Government Support to Bolster Growth of Regenerative Medicines Market.....III-50
Organ Transplantations in China: Years 2010 to 2013 in Review.....III-50
Transplantation Tourism in China.....III-50
1$75
   Strategic Corporate Development.....III-51
B. Market Analytics.....III-51
Table 55: Chinese Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-51
1$200
   A. Market Analysis.....III-52
Current and Future Analysis.....III-52
Stem Cell Therapy Market Poised for Robust Growth.....III-52
1$75
   Low Organ Transplantation Expenses Boost Medical Tourism.....III-53
Strategic Corporate Development.....III-53
1$75
   B. Market Analytics.....III-54
Table 56: Indian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-54
1$200
   A. Market Analysis.....III-55
Current and Future Analysis.....III-55
Australia.....III-55
Table 57: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart).....III-55
1$200
   Table 58: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart).....III-56
Strategic Corporate Development.....III-56
1$200
   B. Market Analytics.....III-57
Table 59: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-57
1$200
   A. Market Analysis.....III-58
Current and Future Analysis.....III-58
B. Market Analytics.....III-58
Table 60: Latin America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-58
1$200
   Table 61: Latin America 8-Year Perspective for Biopreservation Equipment and Media by Geographic Region - Percentage Share Breakdown of Dollar Revenues for Brazil, and Rest of Latin America Markets for Years 2013, 2015 and 2020 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Current and Future Analysis.....III-60
Despite Challenges, Brazilian Regenerative Medicine Sector Holds Promise.....III-60
A Major Organ Transplant Market.....III-60
1$75
   B. Market Analytics.....III-61
Table 62: Brazilian Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   A. Market Analysis.....III-62
Current and Future Analysis.....III-62
B. Market Analytics.....III-62
Table 63: Rest of Latin-America Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-62
1$200
   A. Market Analysis.....III-63
Current and Future Analysis.....III-63
Israel Stem Cell Research in Full Swing.....III-63
1$75
   Kuwait – A Rapidly Emerging ‘Third World’ Country in Organ Transplants.....III-64
Strategic Corporate Development.....III-64
Core Dynamics, Ltd. – A Key Israeli Player.....III-64
1$75
   B. Market Analytics.....III-65
Table 64: Rest of World Recent Past, Current & Future Analysis for Biopreservation Equipment and Media with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-65
1$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com